Journal
FRONTIERS IN PHARMACOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.755569
Keywords
atherosclerosis; nanomedicine; drug delivery; inflammation; statins
Categories
Funding
- National Institute of General Medical Sciences, National Institutes of Health [R01GM072667]
- Michigan State University
Ask authors/readers for more resources
Nanomedicine is a powerful tool that can target atherosclerotic plaques, and the advances in designing nanoparticles with therapeutic effects on these plaques have been summarized to stimulate further development and future translation.
Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of death in the world. Nanomedicine is a powerful tool that can be engineered to target atherosclerotic plaques for therapeutic and diagnosis purposes. In this review, advances in designing nanoparticles with therapeutic effects on atherosclerotic plaques known as atheroprotective nanomedicine have been summarized to stimulate further development and future translation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
